BP Ventures was among the participants in a round reportedly valuing the EV charging network and technology developer at $525m.
Category: News
Ford finds $130m road to Cavnue
Intelligent road technology developer Cavnue raised the cash in a series A round co-led by Ford Motor Company while two other strategic partners, Globalvia and Landstar, also invested.
Qualified crosses i’s on $95m series C
Salesforce Ventures, an investor in the sales generation software developer since seed stage, returned for a round hiking its overall funding to $158m.
Daily Deal Round Up: April 28, 2022
Call centre software producer Replicant closed a $78m series B round backed by Salesforce Ventures while Ashvattha Therapeutics raised $69m from investors including strategic partner Huadong Medicine.
Green finds new pastures at Dell
Omri Green has departed from venture firm Grove Ventures and will take on an Israel-based partner role at Dell Technologies Capital.
Gupta bids SoftBank goodbye
Vishal Gupta, formerly a director at the SoftBank division that oversees its Vision Funds, has joined TA Associates in a similar role.
Ruqi mobilises $153m in series A round
GAC has returned to lead the Tencent and Guangzhou Public Transport-backed automated taxi developer’s latest round, which included WeRide and Pony.ai.
RVAC Medicines arms itself with funding
GS Group contributed to a series B round that pushed messenger RNA therapeutics and vaccine developer RVAC Medicines’ overall funding to $140m.
Ayar Labs arrows to $130m series C
HPE, Nvidia, GlobalFoundries, Intel Capital, Applied Ventures and Lockheed Martin Ventures helped push the semiconductor technology provider’s total funding past $190m.
Daily Deal Round Up: April 27, 2022
Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.
MassMutual Ventures assembles $300m fund
Massachusetts Mutual Life’s venture capital arm has formed a fourth fund, which will concentrate on European and Asia-Pacific investments.
Biofourmis takes care with $300m series D
CVS Health joined returning backers that could include SoftBank Vision Fund 2, MassMutual Ventures, Jianke and Aviva in a round valuing the digital care service at $1.3bn.
Fu-Gen energises itself with $343m
Migdal and Menora Mivtachim helped supply the renewable energy infrastructure developer with fresh funding which will help expand its operations in the UK and Finland.
Harness pulls in $230m
ServiceNow, Capital One Ventures, Citi Ventures, Splunk Ventures and GV all contributed to the software deployment technology provider’s latest round, valuing it at $3.7bn.